Wuhan Healthgen Biotechnology Corp
688765
Company Profile
Business description
Wuhan Healthgen Biotechnology Corp is engaged in Research, development, production and commercialization of plant-based molecular medicines.
Contact
No. 268, Shendun 5th Road
East Lake New Technology Development Zone
Hubei Province
Wuhan430206
CHNT: +86 2759403931
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
253
Stocks News & Analysis
stocks
The World Cup stock you’ve never heard of
This ASX stock is kicking goals at the FIFA World Cup.
stocks
Chart of the Week: Can WiseTech shares finally bounce back?
Market concerns over governance and AI fears have left shares trading well below the fair value.
stocks
Steep downgrade for wide moat share
Regulatory pressures squeeze growth outlook for wide moat ASX share.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,955.50 | 40.70 | 0.46% |
| CAC 40 | 8,252.66 | 183.58 | -2.18% |
| DAX 40 | 24,897.45 | 567.80 | -2.23% |
| Dow JONES (US) | 52,348.39 | 576.76 | -1.09% |
| FTSE 100 | 10,489.04 | 176.84 | -1.66% |
| HKSE | 24,009.07 | 190.39 | -0.79% |
| NASDAQ | 25,870.65 | 51.96 | 0.20% |
| Nikkei 225 | 68,009.15 | 1,190.10 | 1.78% |
| NZX 50 Index | 13,785.67 | 120.49 | 0.88% |
| S&P 500 | 7,482.71 | 21.14 | -0.28% |
| S&P/ASX 200 | 8,755.50 | 37.40 | 0.43% |
| SSE Composite Index | 4,007.59 | 36.71 | 0.92% |